Manish Potti - 16 Dec 2021 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Reporting relationship: Director
Issuer ticker: OCGN
Reported as of: 16 Dec 2021
Net transaction value: +$64,530
SEC form: 4
Accepted by SEC: 17 Dec 2021, 20:24:13 UTC
Prior SEC filing: 03 Nov 2021
Source filing: View source filing
Reporting owner signature: By: /s/ Manish Potti by Sanjay Subramanian, his attorney-in-fact

Key filing fact

Manish Potti filed Form 4 for Ocugen, Inc. (OCGN) on 17 Dec 2021.

Key facts

This page summarizes Manish Potti's Form 4 filing for Ocugen, Inc. (OCGN).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 17 Dec 2021, 20:24.

Change

Previous filing in this sequence was filed on 03 Nov 2021.
Current net transaction value: +$64,530.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OCGN transaction

Common Stock

Options Exercise

Transaction value: $6,885
Shares: +13,500
Change %
Price: $0.5100
Shares after: 13,500
Date: 16 Dec 2021
Ownership: Direct

OCGN transaction

Common Stock

Options Exercise

Transaction value: $57,645
Shares: +31,500
Change %: +233%
Price: $1.83
Shares after: 45,000
Date: 16 Dec 2021
Ownership: Direct

OCGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 27,695
Date: 16 Dec 2021
Ownership: Held by Scotland Parkway LLC
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OCGN transaction Derivative

Option (Right to Buy)

Award

Transaction value: $0
Shares: +16,335
Change %
Price: $0.000000
Shares after: 16,335
Date: 16 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,335
Exercise price: $5.02
Footnotes: F2

OCGN transaction Derivative

Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: +13,500
Change %: +225%
Price: $0.000000
Shares after: 19,500
Date: 16 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,500
Exercise price: $0.5100
Footnotes: F3

OCGN transaction Derivative

Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: +31,500
Change %: +56%
Price: $0.000000
Shares after: 87,500
Date: 16 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 31,500
Exercise price: $1.83
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Reporting Person is a managing member of Scotland Parkway LLC and has voting and investment power over securities held by Scotland Parkway LLC.

Footnote F2

The option vests monthly in equal installments over three years commencing on January 16, 2022, subject to continued service with Ocugen, Inc. (the "Company") on the applicable vesting dates.

Footnote F3

The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the second day of each month through January 2, 2023, subject to the Reporting Person's continued service with the Company through each such date.

Footnote F4

The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through January 1, 2024, subject to the Reporting Person's continued service with the Company through each such date.